Medicare's new coverage for GLP-1 weight-loss drugs offers a major financial breakthrough for seniors. However, medical experts warn these medications carry heightened risks for those over 65 that demand careful consideration.
The drugs can cause accelerated muscle loss, a critical concern for maintaining mobility and independence in later life. Common side effects like nausea and vomiting lead to dangerous dehydration, increasing the risk of falls and fractures.
Significant, rapid weight loss in older adults has been linked to worse health outcomes. Early research also suggests a possible increased risk of fragility fractures.
GLP-1s slow digestion, which can interfere with the absorption of other essential medications many seniors take daily. Furthermore, the weight often returns when the medication is stopped, potentially leaving users weaker than before.
Experts emphasize that the risk-benefit calculation for these drugs is fundamentally different for older adults. Patients should consult their doctors to create a comprehensive plan that includes muscle protection and an exit strategy.